Zevra Therapeutics, Inc. (ZVRA) Earnings Call Transcript & Summary

Hello, and welcome to the Annual Meeting of Stockholders of KemPharm, Inc. Please note that today's meeting is being recorded. [Operator Instructions] It is now my pleasure to turn today's meeting over to Mr. LaDuane Clifton, who is serving as the Chairman and Secretary of today's meeting. Mr. Clifton, the floor is yours.

Good morning. I'm LaDuane Clifton, the Chief Financial Officer, Secretary and Treasurer of KemPharm. Welcome to KemPharm's 2022 Annual Meeting of Stockholders. Today's virtual-only meeting is a live webcast. We appreciate your attendance, and we hope that this virtual meeting will maximize the participation of stockholders regardless of their location. This technology enables us to reach a larger audience, while also containing our costs. Before I call the meeting to order, I'd like to introduce you to the members of the Board and the business team who are with us here today. All of the members of the Board of Directors are in attendance today, including our President and CEO, Travis Mickle; our Executive Chairman, Richard Pascoe, as well as directors Matt Plooster, Joe Saluri; Tamara Seymour and David Tierney. I would also like to introduce Mark Baxter of E&Y, the company's independent auditors; and Nathan Ajiashvili of Latham & Watkins, the company's counsel, all of whom are available to respond to appropriate questions. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in your notice of annual meeting and proxy statement. After the formal part of our meeting, we will provide you an opportunity to ask any questions you may have. [Operator Instructions] I will now provide the secretary's report regarding the list of stockholders and proof of mailing of notice. I have at this meeting a complete list of the stockholders of record of the company's common stock on May 10, 2022, the record date for this meeting. I also have an affidavit certifying that on May 19, 2022, a notice of annual meeting of stockholders of the company was deposited in the U.S. mail to all stockholders of record at the close of business on May 10, 2022. At this time, I'd like to introduce Ginger Lawrence, of Computershare Trust Company, the company's transfer agent. Ms. Lawrence has been appointed to act as Inspector of Election at today's meeting and has taken and subscribed the customary oath of office to execute her duties with strict impartiality. We will file this oath with the records of the meeting. Her function is to decide upon the qualifications of voters, accept their votes and when balloting on all matters is completed, to tally the final votes. I have been informed by the Inspector of Election that proxies have been received for 22,443,406 shares of the 34,422,503 shares of common stock outstanding on the record date, which represents approximately 65.2% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. There are 2 proposals to be considered by the stockholders at this meeting. If you need a copy of the Form 10-K or the proxy statement, the links have been provided online. The time is now 9:03 on Tuesday, June 28, 2022, and the polls are now open for voting on all matters to be presented. The polls will be closed to voting after we go through the matters to be voted on. The first item of business is the election of 2 directors to serve until the 2025 Annual Meeting and until their successors are elected. The nominees for Director are Travis Mickle and Tamara Seymour. The second item of business today is the ratification of the appointment of E&Y as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2022. These are the only 2 proposals for today's meeting. Now I will review the voting procedures. Voting is by proxy and on the Internet during this meeting. You do not need to vote during this meeting if you have already submitted your signed proxy prior to the meeting. If you have not voted or wish to change your vote, you may do so now by clicking on the link provided online. Any stockholder who has already voted and does not want to change their vote, need not take any further action. Each share of common stock is entitled to one vote. [Voting]

The time is now 9:05 a.m., and the polls are now closed for voting. The preliminary vote results indicate from the Inspector of Election covering the proposal presented at this meeting is as follows: the proposal to elect Travis Mickle and Tamara Seymour as directors of the company is carried; the appointment of E&Y as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2022, is ratified. We expect to report our preliminary voting results or if available to us on a timely basis, our final voting results on a current report on Form 8-K to be filed with the SEC within 4 business days after the end of this meeting. If not earlier reported, we expect to report our final voting results in an amendment to our Form 8-K within 4 business days after the final results are known to us. The 2022 Annual Meeting of Stockholders of KemPharm is now concluded. I would now like to open the floor to Q&A. [Operator Instructions]. Well, now looking at the queue, there are no questions. And so with that, I would like to conclude the meeting. Thank you very much for attending today and take care.